Mangalam Drugs shares hit 5% upper circuit after Vijay Kedia buys stake worth Rs 33 lakh

Mangalam Drugs and Organics

The shares of Mangalam Drugs and Organics jumped 5 percent to hit the upper circuit after ace investor Vijay Kedia's office bought stake worth more than Rs 33 lakh in the firm.

The shares of the company remained locked in the upper circuit at Rs 26.20 apiece, extending gains for the second consecutive session.

Vijay Kedia buys stake in Mangalam Drugs:

According to data on NSE, Kedia Securities Private Limited on December 29 bought around 1.38 lakh shares at a price of Rs 24.15 per share in a bulk deal. This takes the total transaction value to Rs 33.28 lakh.

The price at which the firm bought shares of the company marks a 3 percent discount to the previous closing price of Rs 24.96 per share.

Mangalam Drugs and Organics manufactures Active Pharmaceutical Ingredients (APIs) and intermediates.

Mangalam Drugs share price:

Mangalam Drugs shares have seen a sharp rise recently, jumping nearly 10 percent in the past five days. The stock has however fallen around 68 percent in the past six months, and is down more than 78 percent in 2025 so far.

After hitting a 52-week high of Rs 124.89 apiece on January 1 this year, the stock tumbled 82 percent to hit a fresh 52-week low of Rs 22.8 apiece yesterday. It currently has a market capitalisation of nearly Rs 42 crore.

Follow all LIVE updates from the stock markets here.